TAmiRNA_-_microRNA_Biomarkers_for_more_stability_in_life Harnessing the power of

microRNAs for development

of innovative diagnostic tools
home2020-10-27T17:48:50+01:00

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

our focus:
age-associated
diseases

age_associated_diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

biomarkers for more stability in life

our purpose:
precision
medicine

discovery_and_validation_of_microRNA_biomarkers

TamiRNA is a biotech company specialized in the discovery and validation of microRNA biomarkers. Our mission is to provide validated diagnostic solutions to patients with serious aging-related illnesses. We aim to improve and prolong patient stability, health and quality of life with increasing age.

our technology:
microRNA
signatures

mircoRNA_signatures

We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA levels and clinical parameters.

our focus:
age-associated
diseases

TAmiRNA is actively involved in R&D projects in osteoporosis (OP), cardio-vascular disease (CVD), liver disease and aging. OP and CVD are multifactorial illnesses. Using microRNA signatures we aim to decode the contributing disease factors on a personalized level, and to use this knowledge for better diagnosis.

our products

osteomiR_microRNA_biomarkers_of_bone_quality
thrombomiR_microRNA_biomarkers_of_platelet_function
SARS-CoV-2 Antibody Test

our products

osteomiR_microRNA_biomarkers_of_bone_quality
thrombomiR_microRNA_biomarkers_of_platelet_function
SARS-CoV-2 Antibody Test

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs in any biological matrix.

Kit services

Send us your samples to obtain results for osteomiR™, thrombomiR® or toxomiR® biomarkers by taking advantage of our in-house services.

SARS-CoV-2 PCR Test Service

SARS_COVID_PCR_Logo

TAmiRNA is offering a test service for direct detection of SARS-CoV-2 viral RNA in biological samples.

Click_here_for_your_personalized_microRNA_service_offer

our services

microRNA services

services

Serum, plasma, urine, saliva, exosomes, cells, and tissues … We provide solutions for your biomarker discovery and validation needs.

One-Stop-Shop

Obtain results for osteomiR, thrombomiR,and toxomiR biomarkers in your samples by taking advantage of our inhouseservices.

SARS-CoV-2 PCR Test Service

SARS_COVID_PCR_Logo

TAmiRNA is offering a test service for direct detection of SARS-CoV-2 viral RNA in biological samples.

Click_here_for_your_personalized_microRNA_service_offer

latest news

MedUni Wien “Researcher of the Month” Oktober 2020

By |October 6th, 2020|Categories: biomarker, Liver disease, microRNAs, Personalized medicine|Tags: , , , , |

We want to congratulate Dr. Patrick Starlinger to his award “Researcher of the Month” for his work in cooperation with TAmiRNA GmbH, in Hepatology. "Predicting Postoperative Liver Dysfunction Based on Blood [...]

Read More
 0

Dr. Michael Nodine´s Spike-in technology is nominated for a Houska prize

By |October 1st, 2020|Categories: biomarker, microRNA, microRNA services, Personalized medicine, safety, test service|Tags: , , , , , |

The “Houska“ Prize, awarded annually by the B&C Foundation, is Austria´s biggest private award for applied research. Dr. Michael Nodine, Gregor Mendel Institute of Molecular Plant Biology (GMI), was nominated [...]

Read More
 0

TAmiRNA bietet validierte Coronavirus Antikörpertests und SARS-CoV-2 PCR-Analysen an

By |July 29th, 2020|Categories: Coronavirus, CoV-2, PCR testing service, SARS, SARS-CoV-2 Antibody Test|Tags: , , , |

Read More
 0

MedUni Wien “Researcher of the Month” Oktober 2020

By |October 6th, 2020|Categories: biomarker, Liver disease, microRNAs, Personalized medicine|Tags: , , , , |

We want to congratulate Dr. Patrick Starlinger to his award “Researcher of the Month” for his work in cooperation with TAmiRNA GmbH, in Hepatology. "Predicting Postoperative Liver Dysfunction Based on Blood Derived MicroRNA Signatures." [...]

Read More
 0

Dr. Michael Nodine´s Spike-in technology is nominated for a Houska prize

By |October 1st, 2020|Categories: biomarker, microRNA, microRNA services, Personalized medicine, safety, test service|Tags: , , , , , |

The “Houska“ Prize, awarded annually by the B&C Foundation, is Austria´s biggest private award for applied research. Dr. Michael Nodine, Gregor Mendel Institute of Molecular Plant Biology (GMI), was nominated for his work [...]

Read More
 0

TAmiRNA bietet validierte Coronavirus Antikörpertests und SARS-CoV-2 PCR-Analysen an

By |July 29th, 2020|Categories: Coronavirus, CoV-2, PCR testing service, SARS, SARS-CoV-2 Antibody Test|Tags: , , , |

Read More
 0
read more news
© Copyright TAmiRNA 2019 -